5 reasons why every investor should have Veda Group Ltd on their watchlist

Investors looking for a company with a big future should consider Veda Group Ltd (ASX:VED)

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Veda Group Ltd (ASX: VED) is a company many investors may not know much about. It has only been listed for 18 months and although the broader market has been volatile, Veda's share price has remained subdued.

Veda is the largest credit reference agency in Australia and New Zealand. The services it provides include credit reporting, credit scoring and marketing analytics.

Although the shares seem fully valued at the current price, I believe Veda has qualities that will make it a good long-term investment if purchased at the right price. With that said, here are five reasons investors should have Veda on their watchlist:

1. Proven Performer – Obviously investors should not rely on past performance but it is important to be aware of a company's track record. Veda has a strong track record of growth with over 20 years of consistent growth. This should give investors some confidence that the management team is capable and is focused on improving shareholder returns.

2. Market Leader – Veda is able to leverage its scale to create sustainable competitive advantages. It holds the largest commercial database of individual and business records that enables it to create the most comprehensive analysis and predictions for its clients. These data assets also help grow loyalty to Veda as its clients benefit from stronger relationships with their own customers.

3. Diversification of revenue streams – Veda does not rely on one particular business unit to drive earnings growth. Although consumer risk and commercial risk services have been the traditional drivers of growth for Veda, its marketing services have been growing strongly and there is considerable potential for further growth in that sector. The company also has plans to expand into new segments such as wealth management and legal services.

4. Excellent Margins – Veda operates on an impressive margin of around 43%. The business is capital light and management has been disciplined in maintaining capital expenditure at the same percentage of revenue even as the company has expanded. Although a new competitor may enter the market and possibly force margins down, Veda's competitive advantages means it will be well placed to defend its market share.

5. Regulatory Tailwinds – Veda will benefit from credit reporting legislation that has been introduced recently. Credit providers will now have to implement more comprehensive credit checks when dealing with high risk customers. As Veda is the market leader in providing credit analysis, the new legislation should be a tailwind for earnings moving forward as more financial institutions will require the services it provides.

Foolish takeaway

The impact of a new competitor remains a risk for Veda but the competitive advantages it possess and increasing demand for its services should see it maintain its dominant position.

At the current share price, Veda shares are trading at around 25x FY15 earnings and investors should expect to receive a dividend yield of around 2.5%. Although the long-term outlook is positive, I don't think the short-term upside potential is large enough to take a significant position just yet. Instead, investors might be better off keeping a close eye on Veda and waiting for more value to appear before buying.

If you think Veda looks interesting, then you need to check out The Motley Fool's new small cap report!

Motley Fool contributor Christopher Georges has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »